FDA Inspection 867315 — BioMarin Pharmaceutical Inc.
The FDA completed an inspection of BioMarin Pharmaceutical Inc. on February 17, 2014 in San Rafael, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 17, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- San Rafael, CA (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)